nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP1A1—Dacarbazine—muscle cancer	0.132	0.167	CbGbCtD
Fluvoxamine—CYP2E1—Dacarbazine—muscle cancer	0.102	0.129	CbGbCtD
Fluvoxamine—CYP1A2—Dacarbazine—muscle cancer	0.0588	0.0748	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0562	0.0715	CbGbCtD
Fluvoxamine—CYP3A7—Vincristine—muscle cancer	0.0562	0.0715	CbGbCtD
Fluvoxamine—CYP2E1—Etoposide—muscle cancer	0.0497	0.0633	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—muscle cancer	0.0446	0.0567	CbGbCtD
Fluvoxamine—CYP3A5—Vincristine—muscle cancer	0.0422	0.0536	CbGbCtD
Fluvoxamine—CYP3A5—Etoposide—muscle cancer	0.0386	0.0492	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—muscle cancer	0.0335	0.0426	CbGbCtD
Fluvoxamine—CYP1A2—Etoposide—muscle cancer	0.0288	0.0366	CbGbCtD
Fluvoxamine—ABCB1—Vincristine—muscle cancer	0.0274	0.0349	CbGbCtD
Fluvoxamine—ABCB1—Etoposide—muscle cancer	0.0251	0.032	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—muscle cancer	0.0172	0.0218	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—muscle cancer	0.0166	0.0211	CbGbCtD
Fluvoxamine—CYP3A4—Vincristine—muscle cancer	0.0164	0.0209	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—muscle cancer	0.0162	0.0206	CbGbCtD
Fluvoxamine—CYP3A4—Etoposide—muscle cancer	0.0151	0.0192	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—muscle cancer	0.0103	0.0131	CbGbCtD
Fluvoxamine—Confusional state—Etoposide—muscle cancer	0.000255	0.00119	CcSEcCtD
Fluvoxamine—Cardiac arrest—Doxorubicin—muscle cancer	0.000254	0.00119	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Etoposide—muscle cancer	0.000253	0.00118	CcSEcCtD
Fluvoxamine—Mood swings—Doxorubicin—muscle cancer	0.000253	0.00118	CcSEcCtD
Fluvoxamine—Infection—Etoposide—muscle cancer	0.000251	0.00117	CcSEcCtD
Fluvoxamine—Ataxia—Doxorubicin—muscle cancer	0.000251	0.00117	CcSEcCtD
Fluvoxamine—Asthenia—Dactinomycin—muscle cancer	0.000251	0.00117	CcSEcCtD
Fluvoxamine—Dysuria—Methotrexate—muscle cancer	0.000249	0.00116	CcSEcCtD
Fluvoxamine—Dehydration—Doxorubicin—muscle cancer	0.000248	0.00116	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Etoposide—muscle cancer	0.000248	0.00116	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000248	0.00116	CcSEcCtD
Fluvoxamine—Tachycardia—Etoposide—muscle cancer	0.000247	0.00115	CcSEcCtD
Fluvoxamine—Abdominal pain—Vincristine—muscle cancer	0.000247	0.00115	CcSEcCtD
Fluvoxamine—Body temperature increased—Vincristine—muscle cancer	0.000247	0.00115	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000246	0.00115	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Methotrexate—muscle cancer	0.000245	0.00115	CcSEcCtD
Fluvoxamine—Dry skin—Doxorubicin—muscle cancer	0.000245	0.00114	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Etoposide—muscle cancer	0.000244	0.00114	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000244	0.00114	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000243	0.00114	CcSEcCtD
Fluvoxamine—Hypokalaemia—Doxorubicin—muscle cancer	0.000243	0.00113	CcSEcCtD
Fluvoxamine—Breast disorder—Doxorubicin—muscle cancer	0.000241	0.00113	CcSEcCtD
Fluvoxamine—Anorexia—Etoposide—muscle cancer	0.000241	0.00113	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00024	0.00112	CcSEcCtD
Fluvoxamine—Diarrhoea—Dactinomycin—muscle cancer	0.000239	0.00112	CcSEcCtD
Fluvoxamine—Pneumonia—Methotrexate—muscle cancer	0.000239	0.00112	CcSEcCtD
Fluvoxamine—Drowsiness—Methotrexate—muscle cancer	0.000237	0.00111	CcSEcCtD
Fluvoxamine—Depression—Methotrexate—muscle cancer	0.000237	0.00111	CcSEcCtD
Fluvoxamine—Hypotension—Etoposide—muscle cancer	0.000236	0.0011	CcSEcCtD
Fluvoxamine—Gastritis—Doxorubicin—muscle cancer	0.000236	0.0011	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000235	0.0011	CcSEcCtD
Fluvoxamine—Muscular weakness—Doxorubicin—muscle cancer	0.000235	0.0011	CcSEcCtD
Fluvoxamine—Renal failure—Methotrexate—muscle cancer	0.000233	0.00109	CcSEcCtD
Fluvoxamine—Abdominal distension—Doxorubicin—muscle cancer	0.000232	0.00108	CcSEcCtD
Fluvoxamine—Stomatitis—Methotrexate—muscle cancer	0.000231	0.00108	CcSEcCtD
Fluvoxamine—Conjunctivitis—Methotrexate—muscle cancer	0.000231	0.00108	CcSEcCtD
Fluvoxamine—Asthma—Doxorubicin—muscle cancer	0.000231	0.00108	CcSEcCtD
Fluvoxamine—Influenza—Doxorubicin—muscle cancer	0.000231	0.00108	CcSEcCtD
Fluvoxamine—Dysphagia—Doxorubicin—muscle cancer	0.000231	0.00108	CcSEcCtD
Fluvoxamine—Hypersensitivity—Vincristine—muscle cancer	0.00023	0.00107	CcSEcCtD
Fluvoxamine—Sweating—Methotrexate—muscle cancer	0.000228	0.00106	CcSEcCtD
Fluvoxamine—Paraesthesia—Etoposide—muscle cancer	0.000227	0.00106	CcSEcCtD
Fluvoxamine—Haematuria—Methotrexate—muscle cancer	0.000226	0.00106	CcSEcCtD
Fluvoxamine—Pancreatitis—Doxorubicin—muscle cancer	0.000226	0.00106	CcSEcCtD
Fluvoxamine—Dyspnoea—Etoposide—muscle cancer	0.000225	0.00105	CcSEcCtD
Fluvoxamine—Somnolence—Etoposide—muscle cancer	0.000225	0.00105	CcSEcCtD
Fluvoxamine—Angina pectoris—Doxorubicin—muscle cancer	0.000225	0.00105	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000225	0.00105	CcSEcCtD
Fluvoxamine—Epistaxis—Methotrexate—muscle cancer	0.000224	0.00105	CcSEcCtD
Fluvoxamine—Asthenia—Vincristine—muscle cancer	0.000224	0.00105	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—muscle cancer	0.000222	0.00104	CcSEcCtD
Fluvoxamine—Bronchitis—Doxorubicin—muscle cancer	0.000222	0.00104	CcSEcCtD
Fluvoxamine—Agranulocytosis—Methotrexate—muscle cancer	0.000222	0.00104	CcSEcCtD
Fluvoxamine—Rash—Dactinomycin—muscle cancer	0.00022	0.00103	CcSEcCtD
Fluvoxamine—Decreased appetite—Etoposide—muscle cancer	0.00022	0.00103	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000218	0.00102	CcSEcCtD
Fluvoxamine—Fatigue—Etoposide—muscle cancer	0.000218	0.00102	CcSEcCtD
Fluvoxamine—Pain—Etoposide—muscle cancer	0.000216	0.00101	CcSEcCtD
Fluvoxamine—Constipation—Etoposide—muscle cancer	0.000216	0.00101	CcSEcCtD
Fluvoxamine—Dysuria—Doxorubicin—muscle cancer	0.000216	0.00101	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000214	0.001	CcSEcCtD
Fluvoxamine—Haemoglobin—Methotrexate—muscle cancer	0.000214	0.001	CcSEcCtD
Fluvoxamine—Diarrhoea—Vincristine—muscle cancer	0.000214	0.000998	CcSEcCtD
Fluvoxamine—Hepatitis—Methotrexate—muscle cancer	0.000213	0.000996	CcSEcCtD
Fluvoxamine—Haemorrhage—Methotrexate—muscle cancer	0.000213	0.000996	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—muscle cancer	0.000213	0.000995	CcSEcCtD
Fluvoxamine—Pharyngitis—Methotrexate—muscle cancer	0.000212	0.000989	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Methotrexate—muscle cancer	0.000211	0.000984	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00021	0.000983	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—muscle cancer	0.00021	0.000981	CcSEcCtD
Fluvoxamine—Urethral disorder—Methotrexate—muscle cancer	0.000209	0.000976	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—muscle cancer	0.000209	0.000975	CcSEcCtD
Fluvoxamine—Feeling abnormal—Etoposide—muscle cancer	0.000208	0.000974	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000208	0.000972	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—muscle cancer	0.000208	0.00097	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—muscle cancer	0.000207	0.000966	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Etoposide—muscle cancer	0.000207	0.000966	CcSEcCtD
Fluvoxamine—Dizziness—Vincristine—muscle cancer	0.000206	0.000964	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—muscle cancer	0.000206	0.000961	CcSEcCtD
Fluvoxamine—Visual impairment—Methotrexate—muscle cancer	0.000205	0.00096	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000204	0.000952	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—muscle cancer	0.000202	0.000944	CcSEcCtD
Fluvoxamine—Erythema multiforme—Methotrexate—muscle cancer	0.000202	0.000942	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000202	0.000942	CcSEcCtD
Fluvoxamine—Urticaria—Etoposide—muscle cancer	0.000201	0.000938	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—muscle cancer	0.0002	0.000936	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—muscle cancer	0.0002	0.000936	CcSEcCtD
Fluvoxamine—Body temperature increased—Etoposide—muscle cancer	0.0002	0.000934	CcSEcCtD
Fluvoxamine—Abdominal pain—Etoposide—muscle cancer	0.0002	0.000934	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—muscle cancer	0.0002	0.000934	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—muscle cancer	0.0002	0.000934	CcSEcCtD
Fluvoxamine—Eye disorder—Methotrexate—muscle cancer	0.000199	0.000931	CcSEcCtD
Fluvoxamine—Tinnitus—Methotrexate—muscle cancer	0.000199	0.000929	CcSEcCtD
Fluvoxamine—Vomiting—Vincristine—muscle cancer	0.000198	0.000927	CcSEcCtD
Fluvoxamine—Cardiac disorder—Methotrexate—muscle cancer	0.000198	0.000924	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—muscle cancer	0.000197	0.000921	CcSEcCtD
Fluvoxamine—Rash—Vincristine—muscle cancer	0.000197	0.00092	CcSEcCtD
Fluvoxamine—Dermatitis—Vincristine—muscle cancer	0.000197	0.000919	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—muscle cancer	0.000196	0.000916	CcSEcCtD
Fluvoxamine—Headache—Vincristine—muscle cancer	0.000196	0.000914	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000194	0.000909	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—muscle cancer	0.000194	0.000906	CcSEcCtD
Fluvoxamine—Angiopathy—Methotrexate—muscle cancer	0.000193	0.000904	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—muscle cancer	0.000193	0.000901	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—muscle cancer	0.000192	0.000897	CcSEcCtD
Fluvoxamine—Chills—Methotrexate—muscle cancer	0.000191	0.000894	CcSEcCtD
Fluvoxamine—Alopecia—Methotrexate—muscle cancer	0.000188	0.00088	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—muscle cancer	0.000188	0.000878	CcSEcCtD
Fluvoxamine—Mental disorder—Methotrexate—muscle cancer	0.000187	0.000873	CcSEcCtD
Fluvoxamine—Hypersensitivity—Etoposide—muscle cancer	0.000186	0.00087	CcSEcCtD
Fluvoxamine—Malnutrition—Methotrexate—muscle cancer	0.000186	0.000867	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—muscle cancer	0.000186	0.000867	CcSEcCtD
Fluvoxamine—Nausea—Vincristine—muscle cancer	0.000185	0.000866	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—muscle cancer	0.000185	0.000865	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—muscle cancer	0.000185	0.000862	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—muscle cancer	0.000185	0.000862	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000184	0.000858	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—muscle cancer	0.000183	0.000856	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000182	0.000852	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—muscle cancer	0.000182	0.00085	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—muscle cancer	0.000182	0.000849	CcSEcCtD
Fluvoxamine—Asthenia—Etoposide—muscle cancer	0.000181	0.000848	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—muscle cancer	0.000181	0.000845	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—muscle cancer	0.000179	0.000839	CcSEcCtD
Fluvoxamine—Pruritus—Etoposide—muscle cancer	0.000179	0.000836	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—muscle cancer	0.000178	0.000831	CcSEcCtD
Fluvoxamine—Vision blurred—Methotrexate—muscle cancer	0.000175	0.000817	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—muscle cancer	0.000175	0.000815	CcSEcCtD
Fluvoxamine—Diarrhoea—Etoposide—muscle cancer	0.000173	0.000808	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—muscle cancer	0.000172	0.000806	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—muscle cancer	0.000172	0.000804	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—muscle cancer	0.000172	0.000804	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—muscle cancer	0.000172	0.000801	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—muscle cancer	0.000171	0.0008	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—muscle cancer	0.000167	0.000782	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—muscle cancer	0.000167	0.000782	CcSEcCtD
Fluvoxamine—Dizziness—Etoposide—muscle cancer	0.000167	0.000781	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—muscle cancer	0.000167	0.000779	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—muscle cancer	0.000166	0.000776	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—muscle cancer	0.000166	0.000774	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—muscle cancer	0.000165	0.00077	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—muscle cancer	0.000163	0.000762	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—muscle cancer	0.000162	0.000757	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—muscle cancer	0.000162	0.000756	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—muscle cancer	0.000161	0.000751	CcSEcCtD
Fluvoxamine—Vomiting—Etoposide—muscle cancer	0.000161	0.000751	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—muscle cancer	0.000161	0.000751	CcSEcCtD
Fluvoxamine—Rash—Etoposide—muscle cancer	0.000159	0.000745	CcSEcCtD
Fluvoxamine—Dermatitis—Etoposide—muscle cancer	0.000159	0.000744	CcSEcCtD
Fluvoxamine—Headache—Etoposide—muscle cancer	0.000158	0.00074	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—muscle cancer	0.000158	0.00074	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—muscle cancer	0.000158	0.000738	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—muscle cancer	0.000158	0.000738	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—muscle cancer	0.000158	0.000738	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—muscle cancer	0.000158	0.000737	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—muscle cancer	0.000157	0.000735	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—muscle cancer	0.000156	0.000729	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—muscle cancer	0.000156	0.000729	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—muscle cancer	0.000155	0.000726	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—muscle cancer	0.000154	0.000722	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—muscle cancer	0.000153	0.000713	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—muscle cancer	0.000151	0.000708	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—muscle cancer	0.000151	0.000708	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—muscle cancer	0.00015	0.000703	CcSEcCtD
Fluvoxamine—Nausea—Etoposide—muscle cancer	0.00015	0.000702	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000149	0.000697	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—muscle cancer	0.000149	0.000694	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—muscle cancer	0.000149	0.000694	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—muscle cancer	0.000148	0.000693	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—muscle cancer	0.000148	0.00069	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—muscle cancer	0.000146	0.000684	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—muscle cancer	0.000145	0.000677	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—muscle cancer	0.000144	0.000675	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—muscle cancer	0.000144	0.000675	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—muscle cancer	0.000144	0.000673	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—muscle cancer	0.000144	0.000672	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—muscle cancer	0.000142	0.000663	CcSEcCtD
Fluvoxamine—Hypotension—Methotrexate—muscle cancer	0.000142	0.000661	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—muscle cancer	0.000141	0.00066	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—muscle cancer	0.00014	0.000655	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—muscle cancer	0.000139	0.00065	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—muscle cancer	0.000139	0.000648	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000138	0.000645	CcSEcCtD
Fluvoxamine—Insomnia—Methotrexate—muscle cancer	0.000137	0.00064	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—muscle cancer	0.000137	0.000639	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—muscle cancer	0.000137	0.000639	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—muscle cancer	0.000137	0.000639	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—muscle cancer	0.000136	0.000637	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—muscle cancer	0.000136	0.000635	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—muscle cancer	0.000135	0.000632	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—muscle cancer	0.000135	0.000631	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—muscle cancer	0.000135	0.000629	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—muscle cancer	0.000134	0.000625	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—muscle cancer	0.000133	0.000623	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—muscle cancer	0.000132	0.000618	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—muscle cancer	0.000132	0.000615	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—muscle cancer	0.000131	0.000613	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000131	0.000613	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000131	0.000611	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—muscle cancer	0.000131	0.00061	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—muscle cancer	0.00013	0.000609	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—muscle cancer	0.00013	0.000605	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—muscle cancer	0.000129	0.000603	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—muscle cancer	0.000129	0.000601	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000128	0.0006	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—muscle cancer	0.000128	0.000598	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000127	0.000592	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—muscle cancer	0.000125	0.000584	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—muscle cancer	0.000125	0.000583	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000124	0.000579	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—muscle cancer	0.000123	0.000573	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—muscle cancer	0.00012	0.000562	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—muscle cancer	0.00012	0.000559	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—muscle cancer	0.00012	0.000559	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000119	0.000558	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—muscle cancer	0.000119	0.000554	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—muscle cancer	0.000118	0.00055	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—muscle cancer	0.000117	0.000546	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—muscle cancer	0.000117	0.000545	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—muscle cancer	0.000115	0.000539	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—muscle cancer	0.000114	0.000533	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000113	0.000529	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—muscle cancer	0.000113	0.000528	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—muscle cancer	0.000112	0.000524	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—muscle cancer	0.000112	0.000524	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—muscle cancer	0.000112	0.000521	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—muscle cancer	0.000109	0.000508	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—muscle cancer	0.000108	0.000505	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000107	0.000501	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—muscle cancer	0.000107	0.000501	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—muscle cancer	0.000104	0.000487	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—muscle cancer	0.000104	0.000484	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—muscle cancer	0.000104	0.000484	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—muscle cancer	0.000104	0.000484	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—muscle cancer	0.0001	0.000468	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—muscle cancer	9.66e-05	0.000451	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—muscle cancer	9.63e-05	0.00045	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—muscle cancer	9.55e-05	0.000446	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—muscle cancer	9.54e-05	0.000446	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—muscle cancer	9.49e-05	0.000443	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—muscle cancer	9.41e-05	0.00044	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—muscle cancer	9.28e-05	0.000434	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—muscle cancer	9e-05	0.00042	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—muscle cancer	8.97e-05	0.000419	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—muscle cancer	8.67e-05	0.000405	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—muscle cancer	8.34e-05	0.00039	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—muscle cancer	8.27e-05	0.000386	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—muscle cancer	8.26e-05	0.000386	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—muscle cancer	8.22e-05	0.000384	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—muscle cancer	7.79e-05	0.000364	CcSEcCtD
